Pharmacokinetics of lopinavir/ritonavir incombination with rifampicin based TB treatment in children
1 December 2010. Related: Conference reports, Paediatric care, PK and drug interactions, TB coinfection.
Conference reports
Efavirenz versus nevirapine based first linetreatment in a South African cohort
1 December 2010. Related: Conference reports, Antiretrovirals, Pregnancy.
GSK572: 24-week results in treatment-naive and raltegravir-experienced patients
1 December 2010. Related: Conference reports, Antiretrovirals.
Consensus guidelines recommend routine use of genotypic tropism testing: new focus on maraviroc as a switching option (2010)
1 December 2010. Related: Conference reports, Antiretrovirals, Guidelines.
UK studies on bone health: increasedfracture rates reported in HIV-positive people
1 December 2010. Related: Conference reports, Side effects, Weight, diabetes, metabolic complications.
Muscle weakness or pain analysed as possible raltegravir side effect
1 December 2010. Related: Conference reports, Antiretrovirals, Side effects.
Adding maraviroc does not boost CD4s inrandomised trial
1 December 2010. Related: Conference reports, Antiretrovirals.
Switch to twice-daily unboosted atazanavir outdoes switch to once-daily dose
1 December 2010. Related: Conference reports, Antiretrovirals.
Small but higher rates of AIDS and non-AIDS complications with uncontrolled HIV despite CD4s over 350
1 December 2010. Related: Conference reports, Antiretrovirals.
12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, 4-6 November 2010, London
1 December 2010. Related: Conference reports, Weight, diabetes, metabolic complications.
Bio-Alcamid associated with unacceptable risk of complications: no longer recommended as a treatment for facial lipoatrophy
1 December 2010. Related: Conference reports, Side effects, Weight, diabetes, metabolic complications.
First International Workshop on HIV and Ageing, 4-5 October 2010, Baltimore
1 December 2010. Related: Conference reports.
T-cell senescence linked to KS in peoplewith good HIV control
1 December 2010. Related: Conference reports, Cancer and HIV, Basic science and immunology.
Higher risk of potential drug-drug interactions in HIV patients over 60
1 December 2010. Related: Conference reports, PK and drug interactions.
Age raises fracture risk more in HIV-positive people
1 December 2010. Related: Conference reports, Weight, diabetes, metabolic complications.
50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 12-15 September 2010, Boston
1 October 2010. Related: Conference reports.
Raltegravir pharmacokinetics inpregnancy
1 October 2010. Related: Conference reports, Antiretrovirals, Pregnancy.
Low birth weight associated with HAART in pregnancy in Zambia
1 October 2010. Related: Conference reports, Antiretrovirals, Pregnancy.
Bilirubin levels in infants following in utero atazanavir exposure compared to exposure to other antiretrovirals
1 October 2010. Related: Conference reports, Antiretrovirals, Pregnancy.
Novel mutations and shifting susceptibility to darunavir and tipranavir
1 October 2010. Related: Conference reports, Antiretrovirals, Drug resistance.
Four-drug single-pill antiretroviral equivalent to Atripla at 48 weeks
1 October 2010. Related: Conference reports, Antiretrovirals.
High rates of bone loss and progression with HIV in longitudinal study
1 October 2010. Related: Conference reports, Antiretrovirals, Side effects.
XVIII International AIDS Conference: 18-23 July 2010, Vienna
1 October 2010. Related: Conference reports.
Spray-dried nanoparticle formulation of efavirenz
1 October 2010. Related: Conference reports, Antiretrovirals.
Switching boosted-PIs to raltegravir
1 October 2010. Related: Conference reports, Antiretrovirals, Treatment strategies.
Scaling up: what to do first?
1 October 2010. Related: Conference reports, Treatment strategies, Guidelines.
A new point of care CD4 test
1 October 2010. Related: Conference reports, Basic science and immunology.
Early infant diagnosis
1 October 2010. Related: Conference reports, Antiretrovirals, Paediatric care, Diagnostics.
Efavirenz-based regimens among womenof reproductive age receiving ART in Johannesburg
1 October 2010. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy.
Male circumcision retains effectiveness at reducing risk of HIV infection: 54 month results
1 October 2010. Related: Conference reports, HIV prevention and transmission.
Towards a cure: HIV reservoirs and strategies to control them, 16–17 July 2010, Vienna
1 October 2010. Related: Conference reports, Cure-related research.
Rapporteur summaries
1 October 2010. Related: Conference reports, Basic science and immunology.
XVIII International AIDS Conference: 18-23 July 2010, Vienna
26 August 2010. Related: Conference reports.
Navigating the IAS Vienna conference online
26 August 2010. Related: Conference reports, On the web.
Results from the Caprisa 004 tenofovir microbicide trial
26 August 2010. Related: Conference reports, HIV prevention and transmission, Vaccines and microbicides.
Quadrivalent HPV vaccine reduces genital lesions and HPV acquisition in men
26 August 2010. Related: Conference reports, HIV prevention and transmission, Vaccines and microbicides.
Rilpivirine (TMC-278) vs efavirenz in treatment-naive patients: phase 3 results
26 August 2010. Related: Conference reports, Antiretrovirals.
Once-daily nevirapine extended release (XR) is non-inferior to current formulation
26 August 2010. Related: Conference reports, Antiretrovirals.
GSK572 (dolutegravir): second-generation integrase inhibitor
26 August 2010. Related: Conference reports, Antiretrovirals.
TBR-652: early results for CCR5 inhibitor
26 August 2010. Related: Conference reports, Antiretrovirals.
Atazanavir/r plus maraviroc or tenofovir/FTC in treatment-naive patients
26 August 2010. Related: Conference reports, Antiretrovirals.
Unboosted twice-daily atazanavir plus raltegravir
26 August 2010. Related: Conference reports, Antiretrovirals.
CASCADE analysis of when to start treatment
26 August 2010. Related: Conference reports, Antiretrovirals.
Impact of antiretroviral PMTCT prophylaxis regimens on subsequent maternal disease progression in Kesho Bora
26 August 2010. Related: Conference reports, Antiretrovirals, Pregnancy.
Birth outcomes with antiretroviral exposure
26 August 2010. Related: Conference reports, Antiretrovirals, Pregnancy.
New WHO guidelines for children (July 2010)
26 August 2010. Related: Conference reports, Paediatric care, Guidelines.
Early treatment for infants is cost-effective
26 August 2010. Related: Conference reports, Paediatric care.
No difference in outcomes for children initiating treatment with a protease inhibitor or an NNRTI nor with viral load switching strategies in PENPACT-1
26 August 2010. Related: Conference reports, Antiretrovirals, Paediatric care.
Tablets more acceptable than syrups in the ARROW trial
26 August 2010. Related: Conference reports, Antiretrovirals, Treatment strategies, Paediatric care.
Paediatric formulation of TMC 278
26 August 2010. Related: Conference reports, Antiretrovirals, Paediatric care.
Smoking and atazanavir levels
26 August 2010. Related: Conference reports, PK and drug interactions.
Darunavir/ritonavir and rosuvastatin
26 August 2010. Related: Conference reports, PK and drug interactions.
Lime juice is not a microbicide: do not try at home
26 August 2010. Related: Conference reports, Women's health, HIV prevention and transmission.
2nd Joint Conference of BHIVA with BASHH, 20-23 April 2010, Manchester
1 June 2010. Related: Conference reports.
HAART use among women in UK receiving treatment prior to conception
1 June 2010. Related: Conference reports, Pregnancy.
Duration of ruptured membranes and vertical transmission in the UK
1 June 2010. Related: Conference reports, Pregnancy.
Significant rates of unplanned pregnancies among young women born with HIV
1 June 2010. Related: Conference reports, Pregnancy, Paediatric care.
Route of HCV transmission in HIV-positive gay men is unlikely to be from semen
1 June 2010. Related: Conference reports, Hepatitis coinfection.
75% HIV-positive children have insufficient levels of Vitamin D
1 June 2010. Related: Conference reports, Paediatric care, Side effects, Weight, diabetes, metabolic complications.
Increase in LGV cases in gay men reported in the UK
1 June 2010. Related: Conference reports.
High rates of osteopenia and osteoporosis: importance of DEXA monitoring
1 June 2010. Related: Conference reports, Side effects, Weight, diabetes, metabolic complications.
Summaries of other studies
1 June 2010. Related: Conference reports, HIV prevention and transmission.
11th International Workshop on Clinical Pharmacology of HIV Therapy, 7-9 April, 2010, Sorrento, Italy
1 June 2010. Related: Conference reports, PK and drug interactions.
Atazanavir absorption maximised with food
1 June 2010. Related: Conference reports, PK and drug interactions.
Methadone levels reduced moderately by rilpivirine
1 June 2010. Related: Conference reports, PK and drug interactions.